Estimation of the influence of differentiated therapy on the state of eicosanoids in patients with chronic obstructive pulmonary disease combined with coronary heart disease
JavaScript is disabled for your browser. Some features of this site may not work without it.
Estimation of the influence of differentiated therapy on the state of eicosanoids in patients with chronic obstructive pulmonary disease combined with coronary heart disease